E-LIB Suche - Ergebnisse für: Iveson, Timothy J

1

Codon-specific KRAS mutations predict survival benefit of t..:

van de Haar, Joris ; Ma, Xuhui ; Ooft, Salo N....
Nature Medicine. 29 (2023) 3 - p. 605-614 , 2023

Link: https://doi.org/10.1038/..

2

SCOT: Tumor Sidedness and the Influence of Adjuvant Chemoth..:

Saunders, Mark P. ; Iype, Rohan ; Kelly, Caroline...
Clinical Colorectal Cancer. 22 (2023) 2 - p. 231-237 , 2023

Link: https://doi.org/10.1016/..

3

Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A U..:

Stavraka, Chara ; Pouptsis, Athanasios ; Synowiec, Alicja...
Clinical Colorectal Cancer. 20 (2021) 4 - p. 342-349 , 2021

Link: https://doi.org/10.1016/..

4

The Early Impact of the IDEA Collaboration Results: How the..:

Iveson, Timothy ; Hanna, Catherine ; Iveson, Poppy...
JNCI Cancer Spectrum. 5 (2021) 4 - p. , 2021

Link: https://doi.org/10.1093/..

5

Do clinical trials change practice? A longitudinal, interna..:

Hanna, Catherine R. ; Boyd, Kathleen A. ; Wincenciak, Joanna...
Cancer Treatment and Research Communications. 28 (2021) - p. 100445 , 2021

Link: https://doi.org/10.1016/..

6

Systemic chemotherapy with or without cetuximab in patients..:

Bridgewater, John A ; Pugh, Siân A ; Maishman, Tom...
The Lancet Oncology. 21 (2020) 3 - p. 398-411 , 2020

Link: https://doi.org/10.1016/..

7

A new prognostic and predictive tool for shared decision ma..:

Sobrero, Alberto F. ; Puccini, Alberto ; Shi, Qian...
European Journal of Cancer. 138 (2020) - p. 182-188 , 2020

Link: https://doi.org/10.1016/..

8

Guidelines for time-to-event end-point definitions in adjuv..:

Cohen, Romain ; Vernerey, Dewi ; Bellera, Carine...
European Journal of Cancer. 130 (2020) - p. 63-71 , 2020

Link: https://doi.org/10.1016/..

9

Review of metastatic colorectal cancer treatment pathways a..:

Iveson, Timothy ; Carter, Angela M. ; Shiu, Kai-Keen...
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

10

Pattern Recognition Receptor Polymorphisms as Predictors of..:

Gray, Victoria ; Briggs, Sarah ; Palles, Claire...
JNCI: Journal of the National Cancer Institute. 111 (2019) 8 - p. 828-836 , 2019

Link: https://doi.org/10.1093/..

11

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine ..:

Iveson, Timothy J ; Kerr, Rachel S ; Saunders, Mark P...
The Lancet Oncology. 19 (2018) 4 - p. 562-578 , 2018

Link: https://doi.org/10.1016/..

12

SCOT: a comparison of cost-effectiveness from a large rando..:

Robles-Zurita, José ; Boyd, Kathleen A. ; Briggs, Andrew H....
British Journal of Cancer. 119 (2018) 11 - p. 1332-1338 , 2018

Link: https://doi.org/10.1038/..

13

The IDEA (International Duration Evaluation of Adjuvant Che..:

for the IDEA Steering Committee ; André, Thierry ; Iveson, Timothy...
Current Colorectal Cancer Reports. 9 (2013) 3 - p. 261-269 , 2013

Link: https://doi.org/10.1007/..

14

Response to third-line endocrine treatment for advanced bre..:

Iveson, Timothy J. ; Ahern, Julie ; Smith, Ian E.
European Journal of Cancer. 29 (1993) 4 - p. 572-574 , 1993

Link: https://doi.org/10.1016/..

15

Codon-specific KRAS mutations predict survival benefit of t..:

van de Haar, Joris ; Ma, Xuhui ; Ooft, Salo N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033412/. , 2023

Link: http://www.ncbi.nlm.nih...